| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |